Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion–targeted Prostate Biopsy Outcomes》.pdfVIP

EURURO-6252; No. of Pages 6 E U R O P E A N U R O L O G Y X X X ( 2 0 1 5 ) X X X – X X X ava ilable at journa l homepage: www.europea Prostate Cancer Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion–targeted Prostate Biopsy Outcomes Xiaosong Meng a, Andrew B. Rosenkrantz b, Neil Mendhiratta c, Michael Fenstermaker c, Richard Huang a, James S. Wysock a,e, Marc A. Bjurlin a,f , Susan Marshall a, Fang-Ming Deng d, Ming Zhou d, Jonathan Melamed d, William C. Huang a, Herbert Lepor a, Samir S. Taneja a,b, * a Department of Urology, NYU Langone Medical Center, New York, NY, USA; b Department of Radiology, NYU Langone Medical Center, New York, NY, USA; c School of Medicine, NYU Langone Medical Center, New York, NY, USA; d Department of Pathology, NYU Langone Medical Center, New York, NY, USA; e Department of Urology, New York Hospital Queens, Flushing, NY, USA; f Department of Urology, St. Barnabas Hospital, Bronx, NY, USA Article info Abstract Article history: Background: Increasing evidence supports the use of magnetic resonance imaging (MRI)-ultrasound Accepted June 6, 2015 fusion–targeted prostate biopsy (MRF-TB) to improve the detection of clinically significant prostate cancer (PCa) while limiting detection of indolent disease compared to systematic 12-core biopsy (SB). Associate Editor: Objective: To compare MRF-TB and SB results and investigate the relationship between biopsy James Catto outcomes and prebiopsy MRI.